Vitrolife AB has terminated its market maker agreement with Remium due to the increased share trading. The agreement will cease on 2014-11-21. No new market maker has been appointed.
Gothenburg, August 22, 2014
VITROLIFE AB (publ)
Thomas Axelsson, CEO
Queries should be addressed to:
Mikael Engblom, CFO, tel 46 31 721 80 14
Vitrolife is required to publish the information in this press release in accordance with the Swedish Securities Market Act and/or the Financial Instruments Trading Act. The information was submitted for publication on August 22, 2014 at 2:00 p.m.
This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.